These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2459090

  • 21. Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates.
    Welte K, Bonilla MA, Gillio AP, Boone TC, Potter GK, Gabrilove JL, Moore MA, O'Reilly RJ, Souza LM.
    J Exp Med; 1987 Apr 01; 165(4):941-8. PubMed ID: 3494094
    [Abstract] [Full Text] [Related]

  • 22. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
    Fulton R, Gasper PW, Ogilvie GK, Boone TC, Dornsife RE.
    Exp Hematol; 1991 Sep 01; 19(8):759-67. PubMed ID: 1714401
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The effects of interleukin-3, GM-CSF, and G-CSF on the growth kinetics of colony-forming cells in myelodysplastic syndromes.
    Schipperus M, Sonneveld P, Lindemans J, Hagemeijer A, Vink N, Pegels J, Abels J.
    Leukemia; 1990 Apr 01; 4(4):267-72. PubMed ID: 1694940
    [Abstract] [Full Text] [Related]

  • 25. Neutrophil kinetics of recombinant human granulocyte colony-stimulating factor-induced neutropenia in rats.
    Okada Y, Kawagishi M, Kusaka M.
    Life Sci; 1990 Apr 01; 47(15):PL65-70. PubMed ID: 1700253
    [Abstract] [Full Text] [Related]

  • 26. [Sweet's syndrome in patient with refractory anemia during recombinant human granulocyte colony stimulating factor therapy].
    Sai M, Kawanishi Y, Itoh Y, Aizawa S, Kawashima T, Koga M, Kuratsuji T, Toyama K.
    Rinsho Ketsueki; 1990 Feb 01; 31(2):245-8. PubMed ID: 1691795
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K, Inoue S, Kumar A.
    Exp Hematol; 1991 Jun 01; 19(5):352-8. PubMed ID: 1709109
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Neutrophil kinetics shortly after initial administration of recombinant human granulocyte colony-stimulating factor: neutrophil alkaline phosphatase activity as an endogenous marker.
    Katoh M, Shirai T, Shikoshi K, Ishii M, Saito M, Kitagawa S.
    Eur J Haematol; 1992 Jul 01; 49(1):19-24. PubMed ID: 1379938
    [Abstract] [Full Text] [Related]

  • 31. In vivo effects of recombinant human granulocyte colony-stimulating factor on normal neutrophil function and membrane effector molecule expression.
    Itoh Y, Kuratsuji T, Tsunawaki S, Aizawa S, Toyama K.
    Int J Hematol; 1991 Dec 01; 54(6):463-9. PubMed ID: 1724390
    [Abstract] [Full Text] [Related]

  • 32. In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor.
    Mayani H, Baines P, Bowen DT, Jacobs A.
    Leukemia; 1989 Jan 01; 3(1):29-32. PubMed ID: 2642575
    [Abstract] [Full Text] [Related]

  • 33. Clinical effect of granulocyte colony-stimulating factor on neutrophils and leukemic cells in myelogenous leukemia: analysis.
    Ishikawa J, Yoshimura M, Matsunashi T, Tominaga N, Teshima H, Hiraoka A, Nakamura H, Shibata H, Masaoka T, Takaku F.
    Jpn J Clin Oncol; 1991 Jun 01; 21(3):169-75. PubMed ID: 1719259
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
    Visani G, Tosi P, Finelli C, Gamberi B, Zauli G, Cenacchi A, Fogli M, Colombini R, Tura S.
    Haematologica; 1992 Jun 01; 77(2):142-5. PubMed ID: 1383105
    [Abstract] [Full Text] [Related]

  • 36. Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor.
    Carulli G, Mattii L, Azzarà A, Brizzi S, Galimberti S, Zucca A, Benedetti E, Petrini M.
    Am J Hematol; 2006 May 01; 81(5):318-23. PubMed ID: 16628714
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report.
    Kobayashi Y, Okabe T, Ozawa K, Chiba S, Hino M, Miyazono K, Urabe A, Takaku F.
    Am J Med; 1989 Feb 01; 86(2):178-82. PubMed ID: 2464280
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.